Subcutaneous IgG replacement after pediatric SCT

Pediatric Transplantation

Volumn 16, Issue 8, 2012, Pages 866-871

  Sundin, Mikael ^a   Nordin, Karin ^b   Jostemyr, Yvonne ^b   Winiarski, Jacek ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

bone marrow transplantation; childhood; hypogammaglobulinemia; immunoglobulin

Indexed keywords

CYCLOSPORIN A; IMMUNOGLOBULIN G; METHOTREXATE; PREDNISOLONE; RAPAMYCIN; TACROLIMUS;

ADOLESCENT; ALLERGIC REACTION; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BACTERIAL INFECTION; CHILD; CONTROLLED STUDY; FAMILY ATTITUDE; FEMALE; GRAFT VERSUS HOST REACTION; HEADACHE; HUMAN; IMMUNOGLOBULIN DEFICIENCY; INFANT; MAJOR CLINICAL STUDY; MALE; MUSCLE HYPERTONIA; MYCOSIS; NEWBORN; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SCHOOL CHILD; VIRUS INFECTION;

ADOLESCENT; AGAMMAGLOBULINEMIA; CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT VS HOST DISEASE; HUMANS; IMMUNOGLOBULIN G; INFANT; INFANT, NEWBORN; INJECTIONS, SUBCUTANEOUS; MALE; QUESTIONNAIRES; RETROSPECTIVE STUDIES; STEM CELL TRANSPLANTATION;

EID: 84868672513     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2012.01783.x     Document Type: Article

References (29)

1. Norlin AC, Sairafi D, Mattsson J, Ljungman P, Ringden O, Remberger M,. Allogeneic stem cell transplantation: Low immunoglobulin levels associated with decreased survival. Bone Marrow Transplant 2008: 41: 267-273.
2. Ringden O, Witherspoon R, Storb R, Ekelund E, Thomas ED,. B cell function in human marrow transplant recipients assessed by direct and indirect hemolysis-in-gel assays. J Immunol 1979: 123: 2729-2734.
3. Omazic B, Hentschke P, Nasman-Bjork I, et al., Reconstitution of the Ig heavy chain CDR3 repertoire after allogeneic haematopoietic stem cell transplantation with myeloablative or reduced-intensity conditioning regimens. Scand J Immunol 2005: 61: 72-81.
4. Storek J, Wells D, Dawson MA, Storer B, Maloney DG,. Factors influencing B lymphopoiesis after allogeneic hematopoietic cell transplantation. Blood 2001: 98: 489-491.
5. Atkinson K,. Reconstruction of the haemopoietic and immune systems after marrow transplantation. Bone Marrow Transplant 1990: 5: 209-226.
6. Sullivan KM, Kopecky KJ, Jocom J, et al., Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation. N Engl J Med 1990: 323: 705-712.
7. Cordonnier C, Chevret S, Legrand M, et al., Should immunoglobulin therapy be used in allogeneic stem-cell transplantation? A randomized, double-blind, dose effect, placebo-controlled, multicenter trial. Ann Intern Med 2003: 139: 8-18.
8. Sullivan KM, Storek J, Kopecky KJ, et al., A controlled trial of long-term administration of intravenous immunoglobulin to prevent late infection and chronic graft-vs.-host disease after marrow transplantation: Clinical outcome and effect on subsequent immune recovery. Biol Blood Marrow Transplant 1996: 2: 44-53.
9. Sokos DR, Berger M, Lazarus HM,. Intravenous immunoglobulin: Appropriate indications and uses in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2002: 8: 117-130.
10. Tomblyn M, Chiller T, Einsele H, et al., Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: A global perspective. Preface. Bone Marrow Transplant 2009: 44: 453-455.
11. Tomblyn M, Chiller T, Einsele H, et al., Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: A global perspective. Biol Blood Marrow Transplant 2009: 15: 1143-1238.
12. Berger M,. A history of immune globulin therapy, from the Harvard crash program to monoclonal antibodies. Curr Allergy Asthma Rep 2002: 2: 368-378.
13. Good RA, Lorenz E,. Historic aspects of intravenous immunoglobulin therapy. Cancer 1991: 68: 1415-1421.
14. Bruton OC,. Agammaglobulinemia. Pediatrics 1952: 9: 722-728.
15. Berger M, Cupps TR, Fauci AS,. Immunoglobulin replacement therapy by slow subcutaneous infusion. Ann Intern Med 1980: 93: 55-56.
16. Leahy MF,. Subcutaneous immunoglobulin home treatment in hypogammaglobulinaemia. Lancet 1986: 2: 48.
17. Moore ML, Quinn JM,. Subcutaneous immunoglobulin replacement therapy for primary antibody deficiency: Advancements into the 21st century. Ann Allergy Asthma Immunol 2008: 101: 114-121; quiz 122-113, 178.
18. Gardulf A, Andersen V, Bjorkander J, et al., Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies: Safety and costs. Lancet 1995: 345: 365-369.
19. Meth MJ, Rosenthal DW, Bonagura VR,. Subcutaneous immunoglobulin infusion to treat infants and toddlers with antibody deficiencies. Ann Allergy Asthma Immunol 2010: 105: 187-188.
20. Remberger M, Ackefors M, Berglund S, et al., Improved survival after allogeneic hematopoietic stem cell transplantation in recent years. A single-center study. Biol Blood Marrow Transplant 2011: 17: 1688-1697.
21. Glucksberg H, Storb R, Fefer A, et al., Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974: 18: 295-304.
22. Abrahamsen TG, Sandersen H, Bustnes A,. Home therapy with subcutaneous immunoglobulin infusions in children with congenital immunodeficiencies. Pediatrics 1996: 98: 1127-1131.
23. Gardulf A,. Immunoglobulin treatment for primary antibody deficiencies: Advantages of the subcutaneous route. BioDrugs 2007: 21: 105-116.
24. Buckley RH, Schiff RI,. The use of intravenous immune globulin in immunodeficiency diseases. N Engl J Med 1991: 325: 110-117.
25. Rand KH, Houck H, Ganju A, Babington RG, Elfenbein GJ,. Pharmacokinetics of cytomegalovirus specific IgG antibody following intravenous immunoglobulin in bone marrow transplant patients. Bone Marrow Transplant 1989: 4: 679-683.
26. Bosi A, De Majo E, Guidi S, et al., Kinetics of anti-CMV antibodies after administration of intravenous immunoglobulins to bone marrow transplant recipients. Haematologica 1990: 75: 109-112.
27. Gardulf A, Nicolay U, Math D, et al., Children and adults with primary antibody deficiencies gain quality of life by subcutaneous IgG self-infusions at home. J Allergy Clin Immunol 2004: 114: 936-942.
28. Zampelli AR,. Improving quality of life at home for pediatric patients and families with primary immune deficiencies using subcutatneous immune globulin infusions. Home Health Care Manag Practice 2007: 19: 341-435.
29. Mighten J,. Home intravenous therapy training for carers of children and young people. Br J Nurs 2007: 16: 272-276.